Try our Advanced Search for more refined results

January 19, 2022

Intrivo Diagnostics, Inc. v. Access Bio, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 19, 2022

    Access Bio Accused Of Breaching $120M COVID Test Kit Deal

    Intrivo Diagnostics Inc. slapped the maker of its COVID-19 tests with a breach of contract suit that accuses Access Bio Inc. of reneging on a $120 million production and distribution deal while creating a "virtually identical" test that competes with its product.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login